Co-Founder & CEO of SpacePharma
Yossi has over 30 years of experience managing large-scale development projects worldwide, jointly with high-profile global space players. He is the former chief commander of the Israeli Satellites Unit at the Intelligence Core, Lt. Colonel, and has led numerous preparations towards 9 successful satellite launches. Yossi holds a BS.c of Business Management from UOP, San Diego, CA, USA and an MBA from Tel Aviv University.
Co-Founder, , General Manager
Having worked as a Biometrician in clinical research at Roche in gastroenterology, Martin became head of economic promotion in the canton Jura, Switzerland, leading the fields of automation, IT, sustainable development, and medical devices successfully with more than 200 company creations. Since 2006 Martin acts as an independent business consultant and serial entrepreneur in the IT, environmental, medical devices, and life-sciences sector. Martin is the founder and co-founder of more than 40 ventures and businesses in Switzerland and brought them to prosperity. In addition, Martin is an active member of various boards of directors of Swiss-based international companies. Martin holds a master's degree in agronomy and a Ph.D. in technical sciences both from ETH- Zurich and a postgraduate degree in environmental science from EPF-Lausanne.
Chief Marketing and Business Development Officer
Paul has more than 40 years of experience in the space domain, working on more than 150 space programs at NASA, the European Space Agency (ESA), and the French Space Agency (CNES). Paul was involved in designing satellites, cameras, and radars for planetary missions to Venus, Mars, Jupiter, Saturn and Titan. He was responsible for the development of the radar altimeter, ensuring the proper mission and landing of the Huygens probe of the Cassini mission on Titan's surface. Paul holds an electrical engineering degree from École Supérieure d'Électricité in Paris and a Ph.D. in Earth and Planetary Sciences from MIT, Cambridge, USA.
Chief Technology Officer
Yair is an experienced mechanical engineer, with a vast experience in the design and manufacturing of various mechanical and fluidic systems. Previously, Yair was a senior mechanical engineer at HP/Scitex Vision (industrial printing), mechanical area manager at Nanometrics (semiconductor industry), engineering projects manager at Strauss Inc. and mechanical engineer advisor at Nanospun (advanced materials and bioprinting industry). Yair holds a B.Sc. in mechanical engineering from Ben Gurion University.
Chief Scientific Officer
Shimon has over 20 years of experience in drug discovery and development of innovative chemical entities in the pharmaceutical industry, working with international corporates including NovaPharmaceutical Corporation, Pharmos Corporation, Nextar Chempharma Solutions Ltd., Azoura Ophthalmics, Shulov, and Innovative Science. He has worked in the tech and R&D arena from preclinical to GMP production of injectables, ocular, oral, and topical drug products, and made significant contributions to 5 NDA (New Drug Application) approvals by the FDA and 4 IND (Investigational New Drugs). He holds a B.Sc. in chemistry, an M.Sc. in pharmaceutical sciences and a Ph.D. in pharmacology from the Hebrew University. He was a post-doctoral fellow at the Walter Reed Army Institute of Research, Washington DC.
Chief Financial Officer
Asher has more than 12 years of financial experience, including fundraising, building financial strategies, and risk assessment solutions. He has supported numerous companies such as Delta Galil and PTK with the establishment of financial infrastructure, taxation grants, government incentive plans, as well as complex audit processes. Asher holds a B.A. in Economics and Accounting and is a certified public accountant.
.JPG)
Director of Organ-on-a-Chip and Single Cell Genomics
Danny has over 10 years of experience and is an expert in the fields of droplet-based antibody (scFv) detection for immunotherapy, droplet-based single-cell RNA sequencing, Organ-on-a-Chip models for pharmaceutical compound safety evaluation, and microfluidic-based nanoparticle synthesis for drug delivery systems. He has 3 registered patents under his name and 12 publications. Danny holds an M.Sc. in biotechnology, a Ph.D. in bioengineering, a postdoctoral in single-cell genomics, and an MBA in the biomedical industry, all from the Hebrew University of Jerusalem. Currently, Danny is a Research Associate at Harvard, USA, in the field of stem cell therapy.
UK Managing Director of SpacePharma
Daniel Campbell is a pioneer in Microgravity research, formulation and manufacturing in orbit, bringing over 20 years of leadership in several disruptive start-up companies. Daniel led in-space robotics business development, marketing and sales at Effective Space (now Astroscale), led electric, connected and smart mobility at Autotalks and Better-Place, and managed mobile product lines for modu and Zoran (now Qualcomm). Daniel is a member of the Royal Aeronautical Society (MRAeS), a certified Project Management Professional (PMP)® and a Master Blackblot Product Management Professional™ (Master BPMP). He holds a B.Sc. in Physics and Mathematics (Talpiot Elite Program) from the Hebrew University of Jerusalem, and an MBA (Summa Cum Laude) from Reichman University (IDC Herzliya).
Tissues and Materials Engineer
Offir holds B.Sc. in materials science and engineering (Summa Cum Laude) from Ben Gurion University, and M.Sc. in tissue engineering from Tel Aviv University. Offir’s master thesis focused on smart bio-polymers for controlled release of growth factors for cardiac tissue engineering. Offir previously worked in Intel as a yield engineer and has extensive lab work experience including cell culture, smart materials, analytical characterization of materials properties and more.
SpacePharma Lab Manager
Almog is a biotechnology engineer and a program mentor at Space-lab, the Ramon foundation program. During her MS.c in the drug discovery lab at Bar-Ilan University, almog led a noval research in the field of modified biotoxin for Alzheimer's disease. Almog has extensive experience in structural bioinformatics, drug discovery, and drug development. Almog holds B.Sc. in biotechnology engineering.
SpacePharma intern
Daniel holds a B.Sc. in Molecular Life-Science and a MSc in Drug Innovation from Utrecht University, with a specialization in organoid and organ-on-a-chip in-vitro models. Besides this he has more than 7 years of experience working with X-Ray Diffraction for biologics and small molecule therapeutics.
Scientific Director of SpacePharma EU
Aaron has over 10 years of experience in bioengineering. He is a postdoctoral research fellow at Biozentrum, University of Basel, as organoids scientist and is engaged in stem cells biology, CRISPR- Cas9 based genetic engineering, and transcriptomics scRNAseq. Aaron holds a Ph.D. from the Hebrew University of Jerusalem where His thesis focused on human kidney and liver Organ-on-a-Chip models for drug development. He interned at Montreal Heart Institute, The Technion and Harvard’s Health Science and Technology department, won the SMART PRIZE 2021 award and was accredited as an assistant professor in Physiology and cell biology. Aaron has 5 publications and a patent under his name.
Project Manager and Electronics Engineer
Vitali has more than 10 years of experience in building miniaturized laboratories designed exclusively to be launched into space. He has led complex international projects integrating experiments from top medical institutions and global space agencies. He has worked as a field service engineer at both Persys Services & Engineering Ltd and Nanometrics Ltd,working closely with Intel F28. He is a qualified electronics engineer and network administrator with honors.
Director of Chemical and Pharmaceutical Applications
Over 24 years of experience in the pharmaceutical industry, Guy served as head of technology R&D in Teva Pharmaceuticals.
Guy holds an Ms.C. in chemical engineering from the Technion and he is an expert in crystallization and pharmaceutical technologies
Co-Founder & CEO of SpacePharma
Yossi has over 30 years of experience managing large-scale development projects worldwide, jointly with high-profile global space players. He is the former chief commander of the Israeli Satellites Unit at the Intelligence Core, Lt. Colonel, and has led numerous preparations towards 9 successful satellite launches. Yossi holds a BS.c of Business Management from UOP, San Diego, CA, USA and an MBA from Tel Aviv University.
Co-Founder, , General Manager
Having worked as a Biometrician in clinical research at Roche in gastroenterology, Martin became head of economic promotion in the canton Jura, Switzerland, leading the fields of automation, IT, sustainable development, and medical devices successfully with more than 200 company creations. Since 2006 Martin acts as an independent business consultant and serial entrepreneur in the IT, environmental, medical devices, and life-sciences sector. Martin is the founder and co-founder of more than 40 ventures and businesses in Switzerland and brought them to prosperity. In addition, Martin is an active member of various boards of directors of Swiss-based international companies. Martin holds a master's degree in agronomy and a Ph.D. in technical sciences both from ETH- Zurich and a postgraduate degree in environmental science from EPF-Lausanne.
Chief Marketing and Business Development Officer
Paul has more than 40 years of experience in the space domain, working on more than 150 space programs at NASA, the European Space Agency (ESA), and the French Space Agency (CNES). Paul was involved in designing satellites, cameras, and radars for planetary missions to Venus, Mars, Jupiter, Saturn and Titan. He was responsible for the development of the radar altimeter, ensuring the proper mission and landing of the Huygens probe of the Cassini mission on Titan's surface. Paul holds an electrical engineering degree from École Supérieure d'Électricité in Paris and a Ph.D. in Earth and Planetary Sciences from MIT, Cambridge, USA.
Chief Technology Officer
Yair is an experienced mechanical engineer, with a vast experience in the design and manufacturing of various mechanical and fluidic systems. Previously, Yair was a senior mechanical engineer at HP/Scitex Vision (industrial printing), mechanical area manager at Nanometrics (semiconductor industry), engineering projects manager at Strauss Inc. and mechanical engineer advisor at Nanospun (advanced materials and bioprinting industry). Yair holds a B.Sc. in mechanical engineering from Ben Gurion University.
Chief Scientific Officer
Shimon has over 20 years of experience in drug discovery and development of innovative chemical entities in the pharmaceutical industry, working with international corporates including NovaPharmaceutical Corporation, Pharmos Corporation, Nextar Chempharma Solutions Ltd., Azoura Ophthalmics, Shulov, and Innovative Science. He has worked in the tech and R&D arena from preclinical to GMP production of injectables, ocular, oral, and topical drug products, and made significant contributions to 5 NDA (New Drug Application) approvals by the FDA and 4 IND (Investigational New Drugs). He holds a B.Sc. in chemistry, an M.Sc. in pharmaceutical sciences and a Ph.D. in pharmacology from the Hebrew University. He was a post-doctoral fellow at the Walter Reed Army Institute of Research, Washington DC.
Chief Financial Officer
Asher has more than 12 years of financial experience, including fundraising, building financial strategies, and risk assessment solutions. He has supported numerous companies such as Delta Galil and PTK with the establishment of financial infrastructure, taxation grants, government incentive plans, as well as complex audit processes. Asher holds a B.A. in Economics and Accounting and is a certified public accountant.
Director of Organ-on-a-Chip and Single Cell Genomics
Danny has over 10 years of experience and is an expert in the fields of droplet-based antibody (scFv) detection for immunotherapy, droplet-based single-cell RNA sequencing, Organ-on-a-Chip models for pharmaceutical compound safety evaluation, and microfluidic-based nanoparticle synthesis for drug delivery systems. He has 3 registered patents under his name and 12 publications. Danny holds an M.Sc. in biotechnology, a Ph.D. in bioengineering, a postdoctoral in single-cell genomics, and an MBA in the biomedical industry, all from the Hebrew University of Jerusalem. Currently, Danny is a Research Associate at Harvard, USA, in the field of stem cell therapy.
UK Managing Director of SpacePharma
Daniel Campbell is a pioneer in Microgravity research, formulation and manufacturing in orbit, bringing over 20 years of leadership in several disruptive start-up companies. Daniel led in-space robotics business development, marketing and sales at Effective Space (now Astroscale), led electric, connected and smart mobility at Autotalks and Better-Place, and managed mobile product lines for modu and Zoran (now Qualcomm). Daniel is a member of the Royal Aeronautical Society (MRAeS), a certified Project Management Professional (PMP)® and a Master Blackblot Product Management Professional™ (Master BPMP). He holds a B.Sc. in Physics and Mathematics (Talpiot Elite Program) from the Hebrew University of Jerusalem, and an MBA (Summa Cum Laude) from Reichman University (IDC Herzliya).
Tissues and Materials Engineer
Offir holds B.Sc. in materials science and engineering (Summa Cum Laude) from Ben Gurion University, and M.Sc. in tissue engineering from Tel Aviv University. Offir’s master thesis focused on smart bio-polymers for controlled release of growth factors for cardiac tissue engineering. Offir previously worked in Intel as a yield engineer and has extensive lab work experience including cell culture, smart materials, analytical characterization of materials properties and more.
SpacePharma Lab Manager
Almog is a biotechnology engineer and a program mentor at Space-lab, the Ramon foundation program. During her MS.c in the drug discovery lab at Bar-Ilan University, almog led a noval research in the field of modified biotoxin for Alzheimer's disease. Almog has extensive experience in structural bioinformatics, drug discovery, and drug development. Almog holds B.Sc. in biotechnology engineering.
SpacePharma intern
Daniel holds a B.Sc. in Molecular Life-Science and a MSc in Drug Innovation from Utrecht University, with a specialization in organoid and organ-on-a-chip in-vitro models. Besides this he has more than 7 years of experience working with X-Ray Diffraction for biologics and small molecule therapeutics.
Scientific Director of SpacePharma EU
Aaron has over 10 years of experience in bioengineering. He is a postdoctoral research fellow at Biozentrum, University of Basel, as organoids scientist and is engaged in stem cells biology, CRISPR- Cas9 based genetic engineering, and transcriptomics scRNAseq. Aaron holds a Ph.D. from the Hebrew University of Jerusalem where His thesis focused on human kidney and liver Organ-on-a-Chip models for drug development. He interned at Montreal Heart Institute, The Technion and Harvard’s Health Science and Technology department, won the SMART PRIZE 2021 award and was accredited as an assistant professor in Physiology and cell biology. Aaron has 5 publications and a patent under his name.
Project Manager and Electronics Engineer
Vitali has more than 10 years of experience in building miniaturized laboratories designed exclusively to be launched into space. He has led complex international projects integrating experiments from top medical institutions and global space agencies. He has worked as a field service engineer at both Persys Services & Engineering Ltd and Nanometrics Ltd,working closely with Intel F28. He is a qualified electronics engineer and network administrator with honors.
Director of Chemical and Pharmaceutical Applications
Over 24 years of experience in the pharmaceutical industry, Guy served as head of technology R&D in Teva Pharmaceuticals.
Guy holds an Ms.C. in chemical engineering from the Technion and he is an expert in crystallization and pharmaceutical technologies
Co-Founder & CEO
Yossi has over 30 years of experience managing large-scale development projects worldwide, jointly with high-profile global space players. He is the former chief commander of the Israeli Satellites Unit at the Intelligence Core, Lt. Colonel, and has led numerous preparations towards 9 successful satellite launches. Yossi holds a BS.c of Business Management from UOP, San Diego, CA, USA and an MBA from Tel Aviv University.
Co-Founder, General Manager
Having worked as a Biometrician in clinical research at Roche in gastroenterology, Martin became head of economic promotion in the canton Jura, Switzerland, leading the fields of automation, IT, sustainable development, and medical devices successfully with more than 200 company creations. Since 2006 Martin acts as an independent business consultant and serial entrepreneur in the IT, environmental, medical devices, and life-sciences sector. Martin is the founder and co-founder of more than 40 ventures and businesses in Switzerland and brought them to prosperity. In addition, Martin is an active member of various boards of directors of Swiss-based international companies. Martin holds a master's degree in agronomy and a Ph.D. in technical sciences both from ETH- Zurich and a postgraduate degree in environmental science from EPF-Lausanne.
David is the founder of Dyn Diagnosis Ltd, has over 20 yearsof experience in the field of medical systems, product development, and medical technology innovation. Formerly the director of the MRI control section and integration manager in corporates such as Soltam Systems Ltd and Elscint. David holds a BSc. in industrial engineering and management from the Technion Institute of Technology.
Rami is the CFO and investment manager of Dido Family Group, a 35-years family-owned business with investments in diverse verticals. Alongside years of experience and expertise in the finance domain, Rami has experience in computing, technology, and space. By joining SpacePharma, Rami fulfilled a lifelong dream to contribute to humankind through the promotion of research and development of impactful, groundbreaking technologies. Additionally, Rami has come full circle in trying to find a cure for CJD inspace, a disease from which his father passed prematurely and after whom the SpacePharma medical-research satellites are named.
Co-Founder & CEO
Yossi has over 30 years of experience managing large-scale development projects worldwide, jointly with high-profile global space players. He is the former chief commander of the Israeli Satellites Unit at the Intelligence Core, Lt. Colonel, and has led numerous preparations towards 9 successful satellite launches. Yossi holds a BS.c of Business Management from UOP, San Diego, CA, USA and an MBA from Tel Aviv University.
Co-Founder, General Manager
Having worked as a Biometrician in clinical research at Roche in gastroenterology, Martin became head of economic promotion in the canton Jura, Switzerland, leading the fields of automation, IT, sustainable development, and medical devices successfully with more than 200 company creations. Since 2006 Martin acts as an independent business consultant and serial entrepreneur in the IT, environmental, medical devices, and life-sciences sector. Martin is the founder and co-founder of more than 40 ventures and businesses in Switzerland and brought them to prosperity. In addition, Martin is an active member of various boards of directors of Swiss-based international companies. Martin holds a master's degree in agronomy and a Ph.D. in technical sciences both from ETH- Zurich and a postgraduate degree in environmental science from EPF-Lausanne.
David is the founder of Dyn Diagnosis Ltd, has over 20 yearsof experience in the field of medical systems, product development, and medical technology innovation. Formerly the director of the MRI control section and integration manager in corporates such as Soltam Systems Ltd and Elscint. David holds a BSc. in industrial engineering and management from the Technion Institute of Technology.
Rami is the CFO and investment manager of Dido Family Group, a 35-years family-owned business with investments in diverse verticals. Alongside years of experience and expertise in the finance domain, Rami has experience in computing, technology, and space. By joining SpacePharma, Rami fulfilled a lifelong dream to contribute to humankind through the promotion of research and development of impactful, groundbreaking technologies. Additionally, Rami has come full circle in trying to find a cure for CJD inspace, a disease from which his father passed prematurely and after whom the SpacePharma medical-research satellites are named.
Entrepreneur, former founder and chairman of Applied Materials (Israel)
Former founder and CEO of KLA (Israel)
In his capacity as Advisor to the Board, Joe brings together a unique combination of Private Equity VC&LBO Investments, Operational Leadership, and Top Management Consulting. An Engineer and MBA by education, Joe’s global career covered 12-years at McKinsey and Company, Senior Investment Executive for the Agnelli/EXOR USA Group and for First Atlantic Capital, and Founder of PROTOSTAR EQUITY PARTNERS (both NYC-based firms). He has chaired the Board of several industrial and growth companies, and is a dedicated practitioner of Strategic and Executional Excellence. Joe is a long standing Member of The Council for US and Italy, and has an extensive business and relationship network across the US and Europe.
Giora Eiland has gained many decades of experience in the fields of security and research in various managerial posts. Today he leverages his experience and international relationships built over decades in the security and strategic planning fields in his ongoing consultancy.
Associate Professor at the School of Pharmacy, Faculty of Medicine, Hebrew University
Prof. Eyal holds a BSc degrees in Pharmacy and in Animal Sciences and an MSc in Pharmacology summa cum laude from the Hebrew University’s Clinical Pharmacy Program (summa cum laude). She has written her Doctoral thesis- in the field of drug movement in the body (pharmacokinetics).
Post-doctoral fellowship in the University of Washington. Since 2011- faculty member of the Institute for Drug Research of the Hebrew University's School of Pharmacy. Current research - mostly in the field of brain diseases, particularly epilepsy and several funded projects related to drug distribution into cancer cells.
Entrepreneur, former founder and chairman of Applied Materials (Israel)
Former founder and CEO of KLA (Israel)
In his capacity as Advisor to the Board, Joe brings together a unique combination of Private Equity VC&LBO Investments, Operational Leadership, and Top Management Consulting. An Engineer and MBA by education, Joe’s global career covered 12-years at McKinsey and Company, Senior Investment Executive for the Agnelli/EXOR USA Group and for First Atlantic Capital, and Founder of PROTOSTAR EQUITY PARTNERS (both NYC-based firms). He has chaired the Board of several industrial and growth companies, and is a dedicated practitioner of Strategic and Executional Excellence. Joe is a long standing Member of The Council for US and Italy, and has an extensive business and relationship network across the US and Europe.
.jpg)
Giora Eiland has gained many decades of experience in the fields of security and research in various managerial posts. Today he leverages his experience and international relationships built over decades in the security and strategic planning fields in his ongoing consultancy.
Associate Professor at the School of Pharmacy, Faculty of Medicine, Hebrew University
Prof. Eyal holds a BSc degrees in Pharmacy and in Animal Sciences and an MSc in Pharmacology summa cum laude from the Hebrew University’s Clinical Pharmacy Program (summa cum laude). She has written her Doctoral thesis- in the field of drug movement in the body (pharmacokinetics).
Post-doctoral fellowship in the University of Washington. Since 2011- faculty member of the Institute for Drug Research of the Hebrew University's School of Pharmacy. Current research - mostly in the field of brain diseases, particularly epilepsy and several funded projects related to drug distribution into cancer cells.
